pentaerythritol tetranitrate has been researched along with Placental Abruption in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Groten, T; Kähler, C; Lehmann, T; Schlembach, D; Schleussner, E; Schneider, U | 1 |
1 trial(s) available for pentaerythritol tetranitrate and Placental Abruption
| Article | Year |
|---|---|
Impact of the nitric oxide-donor pentaerythrityl-tetranitrate on perinatal outcome in risk pregnancies: a prospective, randomized, double-blinded trial.
Topics: Abruptio Placentae; Double-Blind Method; Female; Fetal Growth Retardation; Gestational Age; Humans; Infant, Newborn; Nitric Oxide Donors; Pentaerythritol Tetranitrate; Perinatal Death; Placenta; Placenta Diseases; Placentation; Pregnancy; Pregnancy Outcome; Pregnancy, High-Risk; Premature Birth; Prospective Studies; Ultrasonography, Prenatal; Uterine Artery; Vasodilator Agents | 2014 |